Neurogene Inc.
NGNE
$36.14
$0.511.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 31.51% | 41.61% | 33.62% | 5.87% | 23.01% |
| Gross Profit | -31.51% | -41.61% | -33.62% | -5.87% | -30.68% |
| SG&A Expenses | 66.82% | 0.49% | 11.76% | 11.23% | 26.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.60% | 28.67% | 27.36% | 7.29% | 23.85% |
| Operating Income | -40.60% | -28.67% | -27.36% | -7.29% | -29.54% |
| Income Before Tax | -56.65% | -36.59% | -26.76% | -3.64% | -19.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.65% | -36.59% | -26.76% | -3.64% | -19.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.65% | -36.59% | -26.76% | -3.64% | -19.06% |
| EBIT | -40.60% | -28.67% | -27.36% | -7.29% | -29.54% |
| EBITDA | -41.62% | -29.17% | -28.47% | -7.72% | -31.05% |
| EPS Basic | -46.26% | -28.57% | -11.75% | 17.00% | 4.21% |
| Normalized Basic EPS | -46.26% | -28.59% | -11.17% | 17.00% | 4.21% |
| EPS Diluted | -46.26% | -28.57% | -11.75% | 17.00% | 4.21% |
| Normalized Diluted EPS | -46.26% | -28.59% | -11.17% | 17.00% | 4.21% |
| Average Basic Shares Outstanding | 7.11% | 6.24% | 13.42% | 24.86% | 24.28% |
| Average Diluted Shares Outstanding | 7.11% | 6.24% | 13.42% | 24.86% | 24.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |